164 related articles for article (PubMed ID: 35852664)
1. Fibulin-3 sponges Tiam1 to manipulate MMP-7 activity through β-catenin signaling in oral squamous cell carcinoma.
Guo H; Ji Y; Zhang B; Huang X
Med Oncol; 2022 Jul; 39(10):154. PubMed ID: 35852664
[TBL] [Abstract][Full Text] [Related]
2. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
Yang K; Zhao J; Liu S; Man S
Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
[TBL] [Abstract][Full Text] [Related]
3. Sex determining region Y-box 9 induced microtubule formation and epithelial⁃mesenchymal transition in human oral squamous cell carcinoma CAL27 cells.
Huang S; Zhang QY; He AE; Li HB; Zhang ZX
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):74-80. PubMed ID: 33723940
[TBL] [Abstract][Full Text] [Related]
4. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
5. Fibulin-3 suppresses Wnt/β-catenin signaling and lung cancer invasion.
Chen X; Meng J; Yue W; Yu J; Yang J; Yao Z; Zhang L
Carcinogenesis; 2014 Aug; 35(8):1707-16. PubMed ID: 24480807
[TBL] [Abstract][Full Text] [Related]
6. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
[TBL] [Abstract][Full Text] [Related]
7. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
[TBL] [Abstract][Full Text] [Related]
8. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
9. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin.
Min A; Xiong H; Wang W; Hu X; Wang C; Mao T; Yang L; Huang D; Xia K; Su T
J Oral Pathol Med; 2020 Nov; 49(10):1019-1029. PubMed ID: 32740991
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
Pramanik KK; Nagini S; Singh AK; Mishra P; Kashyap T; Nath N; Alam M; Rana A; Mishra R
Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466
[TBL] [Abstract][Full Text] [Related]
11. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
[TBL] [Abstract][Full Text] [Related]
12. Effects of DSPP and MMP20 Silencing on Adhesion, Metastasis, Angiogenesis, and Epithelial-Mesenchymal Transition Proteins in Oral Squamous Cell Carcinoma Cells.
Aseervatham J; Ogbureke KUE
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630820
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells.
Iwai S; Yonekawa A; Harada C; Hamada M; Katagiri W; Nakazawa M; Yura Y
Int J Oncol; 2010 Nov; 37(5):1095-103. PubMed ID: 20878057
[TBL] [Abstract][Full Text] [Related]
14. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
Wang LH; Xu M; Fu LQ; Chen XY; Yang F
Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
[TBL] [Abstract][Full Text] [Related]
15. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
[TBL] [Abstract][Full Text] [Related]
16. Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.
Zheng S; Wu R; Deng Y; Zhang Q
Bioengineered; 2022 Jan; 13(1):227-241. PubMed ID: 34847839
[TBL] [Abstract][Full Text] [Related]
17. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
[TBL] [Abstract][Full Text] [Related]
19. P120ctn may participate in epithelial-mesenchymal transition in OSCC.
Zhong C; Zuo Z; Ji Q; Feng D
Indian J Cancer; 2016; 53(1):20-4. PubMed ID: 27146732
[TBL] [Abstract][Full Text] [Related]
20. Zeb1 for RCP-induced oral cancer cell invasion and its suppression by resveratrol.
Kim JY; Cho KH; Jeong BY; Park CG; Lee HY
Exp Mol Med; 2020 Jul; 52(7):1152-1163. PubMed ID: 32728068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
